4.8 Article

CDK6 inhibits white to beige fat transition by suppressing RUNX1

Journal

NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-03451-1

Keywords

-

Funding

  1. Tufts Nutrition and Cancer Pilot Project Grant
  2. Tufts CTSI-Catalyst Award [UL1 TR001064]
  3. National Natural Science Foundation of China [81102580]
  4. National Key Basic Research Program of China [2014CB543001, R01 DK098606-02, P30-DK-46200, DAARS-58-1950-7-70]
  5. Robert C and Veronica Atkins endowed Professorship
  6. [DK098830]
  7. [DK102199]
  8. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064] Funding Source: NIH RePORTER
  9. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098606, P30DK046200, R01DK102199, R01DK098830] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Whereas white adipose tissue depots contribute to the development of metabolic diseases, brown and beige adipose tissue has beneficial metabolic effects. Here we show that CDK6 regulates beige adipocyte formation. We demonstrate that mice lacking the CDK6 protein or its kinase domain (K43M) exhibit significant increases beige cell formation, enhanced energy expenditure, better glucose tolerance, and improved insulin sensitivity, and are more resistant to high-fat diet-induced obesity. Re-expression of CDK6 in Cdk6(-/-) mature or precursor cells, or ablation of RUNX1 in K43M mature or precursor cells, reverses these phenotypes. Furthermore, RUNX1 positively regulates the expression of Ucp-1 and Pgc1 alpha by binding to proximal promoter regions. Our findings indicate that CDK6 kinase activity negatively regulates the conversion of fat-storing cells into fat-burning cells by suppressing RUNX1, and suggest that CDK6 may be a therapeutic target for the treatment of obesity and related metabolic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available